ArticleOncoimmunology2022

Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment.

Simone Kloch Bendtsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.